DCVAX

LIVE

Serial Number

76029211

Owner

Northwest Biotherapeutics, Inc.

Attorney

Melissa A. Nowak

First Use Date

Mar 6, 2002

Filing Date

Apr 19, 2000

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

DCVAX Trademark

Serial Number: 76029211 • Registration: 2636385

DCVAX is a trademark filed by Northwest Biotherapeutics, Inc. on April 19, 2000. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Northwest Biotherapeutics, Inc. (8 trademarks)

4800 Montgomery Lane, Suite 800
Bethesda, MD 20814

Entity Type: 03

Legal Representation

Attorney of Record

Melissa A. Nowak

1,556 trademarks filed View all →

Trademark Details

Filing Date

April 19, 2000

Registration Date

October 15, 2002

First Use Anywhere

March 6, 2002

First Use in Commerce

March 6, 2002

Published for Opposition

April 10, 2001

Goods & Services

Vaccines

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Apr 5, 2023 NA89

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Apr 5, 2023 RNL2

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Apr 5, 2023 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 5, 2023 APRE

TEAS SECTION 8 & 9 RECEIVED

Sep 26, 2022 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 15, 2021 REM2

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 29, 2014 TCCA

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Oct 9, 2012 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Oct 9, 2012 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Oct 9, 2012 89AG

TEAS SECTION 8 & 9 RECEIVED

Oct 8, 2012 E89R

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Aug 10, 2009 C15A

ASSIGNED TO PARALEGAL

Apr 29, 2009 PLGL

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Apr 20, 2009 815F

PAPER RECEIVED

Apr 20, 2009 MAIL

CASE FILE IN TICRS

Dec 26, 2007 CFIT

REGISTERED-PRINCIPAL REGISTER

Oct 15, 2002 R.PR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 18, 2002 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Jul 16, 2002 SUPC

PAPER RECEIVED

Jun 27, 2002 MAIL

USE AMENDMENT FILED

Jun 24, 2002 IUAF

NOA MAILED - SOU REQUIRED FROM APPLICANT

Dec 25, 2001 NOAM

OPPOSITION TERMINATED NO. 999999

Oct 30, 2001 OP.T

OPPOSITION DISMISSED NO. 999999

Oct 30, 2001 OP.D

OPPOSITION INSTITUTED NO. 999999

Sep 10, 2001 OP.I

EXTENSION OF TIME TO OPPOSE RECEIVED

May 7, 2001 ETOF

PUBLISHED FOR OPPOSITION

Apr 10, 2001 PUBO

NOTICE OF PUBLICATION

Mar 28, 2001 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 28, 2000 CNSA

ASSIGNED TO EXAMINER

Sep 20, 2000 DOCK

Related Trademarks

More from this Owner

DCVAX

NORTHWEST BIOTHERAPEUTICS

Serial #76325361

More in Same Class